SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Feldman Eric Jay (Last) (First) (Middle) C/O GLYCOMIMETICS, INC 9708 MEDICAL CENTER DRIVE (Street) ROCKVILLE MD 20850 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 03/01/2021	3. Issuer Name and Ticker or Trading Symbol GLYCOMIMETICS INC [ GLYC ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Medical Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1)	50,498	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	(2)	04/16/2029	Common Stock	53,000	11.97	D
Employee Stock Option (right to buy)	(3)	01/21/2030	Common Stock	38,000	4.72	D
Employee Stock Option (right to buy)	(4)	01/19/2031	Common Stock	20,000	3.81	D
Employee Stock Option (right to buy)	(5)	02/18/2031	Common Stock	49,000	3.85	D

Explanation of Responses:

1. The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

2. One-fourth of the shares vested on April 17, 2020; the balance of the shares vest in a series of thirty-six successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.

3. One-fourth of the shares vested on January 22, 2021; the balance of the shares vest in a series of thirty-six successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.

4. One-fourth of the shares vest on January 20, 2022; the balance of the shares vest in a series of thirty-six successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.

5. One-fourth of the shares vest on February 19, 2022; the balance of the shares vest in a series of thirty-six successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.

Remarks:

	/s/ Brian F. Leaf, attorney-in-fact	03/08/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.